Loss of EphA3 Protein Expression Is Associated With Advanced TNM Stage in Clear-Cell Renal Cell Carcinoma
- 1 April 2017
- journal article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 15 (2) , e169-e173
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- High levels of EphA3 expression are associated with high invasive capacity and poor overall survival in hepatocellular carcinomaOncology Reports, 2013
- Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survivalJournal of Gastroenterology, 2012
- Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic MelanomaPLOS ONE, 2011
- Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinomaJournal of Clinical Pathology, 2011
- Exploring the Link between Germline and Somatic Genetic Alterations in Breast CarcinogenesisPLOS ONE, 2010
- Mutational Profiling of Kinases in Human Tumours of Pancreatic Origin Identifies Candidate Cancer Genes in Ductal and Ampulla of Vater CarcinomasPLOS ONE, 2010
- Breast cancer metastases are molecularly distinct from their primary tumorsOncogene, 2007
- Novel Somatic and Germline Mutations in Cancer Candidate Genes in Glioblastoma, Melanoma, and Pancreatic CarcinomaCancer Research, 2007
- Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell linesBiochemical and Biophysical Research Communications, 2006
- Mutational Analysis of the Tyrosine Kinome in Colorectal CancersScience, 2003